Immunome IMNM Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's comprehensive income (loss), net of tax, attributable to parent?
- Immunome (IMNM) reported comprehensive income (loss), net of tax, attributable to parent of -$53.84M in Q1 2026.
- How has Immunome's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Immunome's comprehensive income (loss), net of tax, attributable to parent decreased by 29.1% year-over-year, from -$41.7M to -$53.84M.
- What is the long-term trend for Immunome's comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2022 to 2025), Immunome's comprehensive income (loss), net of tax, attributable to parent has grown at a 78.2% compound annual growth rate (CAGR), from -$37.52M to -$212.45M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric captures all changes in equity during a period resulting from transactions and other events from non-owner sources, excluding net income. It includes items such as unrealized gains or losses on securities and foreign currency translation adjustments. It provides a more holistic view of the company's financial performance beyond traditional accounting profit or loss.